Author

O. Sanmartin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Assay:DNA methylation· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:gene regulatory network inference· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

B. Heidenreich· 1 shared B. Llombart· 1 shared C. Guillen· 1 shared C. P. Pellegrini· 1 shared C. Requena· 1 shared C. Serra-Guillen· 1 shared D. Hervas-Marin· 1 shared E. Nagore· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

B. Heidenreich

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Coding and noncoding somatic mutations in basal cell carcinoma

M. G. Maturo, P. S. Rachakonda, B. Heidenreich, C. P. Pellegrini, N. Srinivas, C. Requena, C. Serra-Guillen, B. Llombart, O. Sanmartin, C. Guillen, L. Di Nardo, K. Peris, M. C. Fargnoli, E. Nagore, R. Kumar

This study examines mutations in coding and noncoding regions of genes and promoters in BCC tumors, finding significant associations between specific mutations and clinical features.

bioRxiv · Oct 16, 2019 · PreprintCancer Biology

Genome wide DNA methylation profiling identifies specific epigenetic features in high-risk cutaneous squamous cell carcinoma.

D. Hervas-Marin, F. Higgins, O. Sanmartin, J. A. Lopez-Guerrero, M. C. Bano, J. C. Igual, I. Quilis, J. Sandoval

This study identifies epigenetic features in high-risk cutaneous squamous cell carcinoma through genome-wide DNA methylation profiling and develops a prognostic model based on methylation signatures.

bioRxiv · Sep 20, 2019Cancer Biology